| Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics |
Globe Newswire |
04/20 |
09:00 |
| $29.6+ BN Life Sciences Consulting Services Market Forecasts to 2034: Rising Drug Complexity, AI & Big Data Adoption, Demand for Real-World Evidence, and Biotech Expansion with Novel Therapies |
Globe Newswire |
04/20 |
08:59 |
| INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:55 |
| INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:53 |
| CORT FINAL DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure |
Globe Newswire |
04/20 |
08:46 |
| INVESTOR NOTICE: Lufax Holding (LU) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:45 |
| INVESTOR NOTICE: Gemini Space Station (GEMI) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:43 |
| INVESTOR NOTICE: Coty Inc. (COTY) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:43 |
| INVESTOR DEADLINE: Navan, Inc. (NAVN) Investors with Substantial Losses Have Opportunity to Lead the Navan Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:41 |
| INVESTOR NOTICE: Hercules Capital (HTGC) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action – Hagens Berman |
Globe Newswire |
04/20 |
08:39 |
| AI & Technology Virtual Investor Conference Agenda Announced for April 23rd |
Globe Newswire |
04/20 |
08:35 |
| Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing |
Globe Newswire |
04/20 |
08:35 |
| INVESTOR DEADLINE: Trip.com Group (TCOM) Investors with Substantial Losses Have Opportunity to Lead the Trip.com Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:33 |
| INVESTOR NOTICE: ODDITY Tech. (ODD) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:33 |
| Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026 |
Globe Newswire |
04/20 |
08:32 |
| INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action – Hagens Berman |
Globe Newswire |
04/20 |
08:30 |
| 1847 Holdings Subsidiary Wolo Receives Approval of Amazon Brand Registry, Expanding E-Commerce Presence |
Globe Newswire |
04/20 |
08:30 |
| When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech |
Globe Newswire |
04/20 |
08:30 |
| Anthony, Linder & Cacomanolis Releases Strategic Analysis on PayPay IPO; Transaction Solidifies "Japan Corridor" to U.S. Capital Markets |
Globe Newswire |
04/20 |
08:30 |
| From Ukraine to the Middle East, GPS Disruption Drives Demand for Next-Generation Defense Technology |
Globe Newswire |
04/20 |
08:30 |
| INVESTOR DEADLINE: Eos Energy (EOSE) Investors with Substantial Losses Have Opportunity to Lead the Eos Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:27 |
| INVESTOR DEADLINE: Driven Brands (DRVN) Investors with Substantial Losses Have Opportunity to Lead the Driven Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:26 |
| Turbo Energy and Hithium Partner to Integrate AI-Driven Energy Optimization Software Into Battery Storage Systems Across Europe and Latin America |
Globe Newswire |
04/20 |
08:20 |
| INVESTOR DEADLINE: Apollo Global Management (APO) Investors with Substantial Losses Have Opportunity to Lead the Apollo Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:18 |
| Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions |
Globe Newswire |
04/20 |
08:15 |
